Profund Advisors’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $230K | Sell |
16,465
-5,878
| -26% | -$82.2K | 0.01% | 824 |
|
|
2025
Q1 | $301K | Sell |
22,343
-11,047
| -33% | -$149K | 0.01% | 670 |
|
|
2024
Q4 | $640K | Buy |
33,390
+14,934
| +81% | +$286K | 0.02% | 404 |
|
|
2024
Q3 | $420K | Sell |
18,456
-8,534
| -32% | -$194K | 0.02% | 612 |
|
|
2024
Q2 | $351K | Sell |
26,990
-36,021
| -57% | -$469K | 0.01% | 630 |
|
|
2024
Q1 | $1.1M | Buy |
63,011
+30,020
| +91% | +$526K | 0.04% | 331 |
|
|
2023
Q4 | $719K | Sell |
32,991
-10,968
| -25% | -$239K | 0.03% | 408 |
|
|
2023
Q3 | $674K | Sell |
43,959
-211
| -0.5% | -$3.24K | 0.04% | 385 |
|
|
2023
Q2 | $1.05M | Buy |
44,170
+11,270
| +34% | +$268K | 0.06% | 305 |
|
|
2023
Q1 | $837K | Buy |
+32,900
| New | +$837K | 0.05% | 348 |
|